Related Experiment Videos
Management of dysfunctional uterine bleeding.
1Department of Obstetrics and Gynaecology, National Women's Hospital, Auckland, New Zealand.
Drugs
|October 1, 1992
Summary
Dysfunctional uterine bleeding treatments offer various options for women. New developments like the levonorgestrel intrauterine device and endometrial resection show promise in reducing menstrual blood loss.
Area of Science:
- Gynecology
- Reproductive Health
Background:
- Dysfunctional uterine bleeding (DUB) causes significant disruption but has been historically under-researched.
- Accurate measurement of menstrual blood loss presents a challenge in DUB research.
Purpose of the Study:
- To review available therapies for dysfunctional uterine bleeding.
- To highlight recent advancements in DUB management.
Main Methods:
- Review of current therapeutic options for DUB.
- Discussion of pharmacological and surgical interventions.
Main Results:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) and combined oral contraceptives are common first-line treatments.
- Progestogen, danazol, levonorgestrel-releasing intrauterine systems (LNG-IUS), and endometrial resection are effective alternatives.
- LNG-IUS and endometrial resection demonstrate significant reductions in menstrual blood loss.
Conclusions:
- Multiple effective treatment options exist for dysfunctional uterine bleeding.
- Novel approaches like LNG-IUS and endometrial resection offer substantial benefits for managing heavy menstrual bleeding.